FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067969 [Registered on: 28/05/2024] Trial Registered Prospectively
Last Modified On: 10/09/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   A randomized controlled clinical trial on effect of topical clotrimazole vs. topical fluconazole vs. topical application of gentian violet in the treatment of otomycosis conducted in a tertiary health care centre  
Scientific Title of Study   A randomized controlled clinical trial on efficacy of topical clotrimazole vs. topical fluconazole vs. topical application of gentian violet in the treatment of otomycosis conducted in a tertiary health care centre  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Srinidhi Ravi 
Designation  Assistant Professor 
Affiliation  K J Somaiya Medical College 
Address  K J Somaiya medical college, Ground floor, opd23, College building, Somaiya Ayurvihar, Sion- Chunabhatti, Mumbai 400022

Mumbai (Suburban)
MAHARASHTRA
400022
India 
Phone  9699693335  
Fax    
Email  srinidhi.ravi@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Srinidhi Ravi 
Designation  Assistant Professor 
Affiliation  K J Somaiya Medical College 
Address  K J Somaiya medical college, Ground floor, opd23, College building, Somaiya Ayurvihar, Sion- Chunabhatti, Mumbai 400022

Mumbai (Suburban)
MAHARASHTRA
400022
India 
Phone  9699693335  
Fax    
Email  srinidhi.ravi@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Srinidhi Ravi 
Designation  Assistant Professor 
Affiliation  K J Somaiya Medical College 
Address  K J Somaiya medical college, Ground floor, opd23, College building, Somaiya Ayurvihar, Sion- Chunabhatti, Mumbai 400022

Mumbai (Suburban)
MAHARASHTRA
400022
India 
Phone  9699693335  
Fax    
Email  srinidhi.ravi@gmail.com  
 
Source of Monetary or Material Support  
K J Somaiya Medical College And Hospital, Somaiya Ayurvihar, Everad Nagar, Sion- Chunabhatti, Mumbai, Maharashtra, India. Pincode- 400022 
 
Primary Sponsor  
Name  K J Somaiya Medical College and Hospital 
Address  K J Somaiya Medical College and Hospital, Somaiya Ayurvihar, Everad Nagar, Sion- Chunbhatti, Mumbai 400022 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Srinidhi Ravi  K J Somaiya Medical College and Hospital  K J Somaiya Medical College and Hospital , Somaiya Ayurvihar, Everad Nagar, Sion- chunabhatti,Mumbai 400022
Mumbai (Suburban)
MAHARASHTRA 
9699693335

srinidhi.ravi@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Academic K J Somaiya Medical College And Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H603||Other infective otitis externa,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Clotrimazole ear drops  Clotrimazole ear drops will be given to patients with otomycosis for topical use 2 drops thrice a day for 1 week 
Comparator Agent  Fluconazole ear drops  Fluconazole ear drops will be given to patients with otomycosis for topical use 2 drops thrice a day 
Comparator Agent  Gentian violet application in external auditory canal  Gentian violet will be applied topically in external auditory canal of patients with otomycosis by clinician once a week  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  patients with otomycosis 
 
ExclusionCriteria 
Details  patients with chronic otitis media
patients with history of ear surgery
patients with history of tympanic membrane perforation 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Earache, aural fullness, ear itching based on visual analogue scale  baseline, 1 week and 2 weeks  
 
Secondary Outcome  
Outcome  TimePoints 
complete clearance of otomycosis as seen on otoscopy by clinician  1 week, 2 week follow up 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "100"
Final Enrollment numbers achieved (India)="100" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   10/06/2024 
Date of Study Completion (India) 10/09/2024 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response - Informed Consent Form

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [srinidhi.ravi@gmail.com].

  6. For how long will this data be available start date provided 01-11-2024 and end date provided 01-11-2029?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - nil
Brief Summary  

RESEARCH QUESTIONS

Which antifungal treatment is more efficacious among fluconazole, clotrimazole and topical gentian violet?


HYPOTHESIS

There is a significant difference in efficacy among fluconazole, clotrimazole and topical gentian violet.

There is no significant difference in efficacy among fluconazole, clotrimazole and topical gentian violet.

AIM

To compare efficacy of topical fluconazole, clotrimazole and topical gentian violet in the treatment of otomycosis.

METHODOLOGY

  1. STUDY DESIGN: Randomized Clinical Trial

  2. STUDY SITE: This study will be conducted on patients suffering from Otomycosis coming in the Out patient ENT department (OPD) , K J Sonaiya Medical college and Hospital 

  3. SAMPLE SIZE: 100

  4. STUDY TIMELINE: 6 months


RESEARCH METHODOLOGY AND ETHICAL CONSIDERATIONS

  1. Ethical considerations:

  1. The study will be conducted after obtaining permission from the Institutional Ethics Committee(IEC)

  2. All data collected will be strictly confidential and used for the purpose of this study as described below.

  3. Written informed valid consent (in English/Hindi/Marathi) will be taken from the subjects before the recruitment of the subjects in this study.

  4. Any deviation from the below given methods/procedure will be informed to the Institutional Ethics Committee and only after the IEC’s approval any changes will be made.

  5. The Proforma for the written informed consent is given herewith.

  1. Subject Population: 

  1. Patients diagnosed with Otomycosis in ENT Out Patient Department will be enrolled in this trial.

  1. Selection criteria:

  1. Male and Female patients above the age of 18 years diagnosed with Otomycosis 

  2. Patients willing to enrol for the trial meeting the above trial.

  1. EXCLUSION CRITERIA:

  1. Patients not willing to be a part of the study.

  2. Patients age below 18 years.

  3. Patients having perforated tympanic membrane in the otomycosis infected ear.

  4. Patients suffering from Chronic suppurative otitis media(CSOM)/Operated for CSOM

  1. Study procedure:

  1. Enrolment of the patients who fulfil inclusion criteria in the study

  2. Recording and documentation of mentioned data collection points as per proforma.

  3. Follow up and review patients after 1 week and 2 weeks and check improvement in signs and symptoms.

  4. Analysis and interpretation of the data collected.


Patients that present to tertiary health care centre with symptoms of ear pain, itching, discharge, reduced hearing, aural fullness, tinnitus will be asked detailed history and undergo an otoscopic examination. Otomycosis will be confirmed by distinctive otoscopic findings which include:

  1. Grayish white mass similar to wet blotting paper. 

  2. Blackish/white spores in the external auditory canal.

All patients will undergo aural toileting in the OP department itself. Treatment option will be given by Random sampling method. Patients will be asked to pick up a chit among three chits each having name of one of the following drugs ie. Fluconazole, clotrimazole and topical application of gentian violet. Fluconazole and Clotrimazole ear drops will be given as 2 drops three times daily. Patients will be taught proper method of ear drops instillation and to avoid the aggravating factors like water/moisture exposure, use of ear buds, oil instillation. In Group 3 patients receiving topical Gentian violet, solution of Gentian Violet will be applied in the external auditory canal weekly once by the medical practitioner. Other medications including Antihistaminics, Analgesics and Anti-inflammatory drugs will be given as per individual case scenarios and symptoms. Patients will be followed up after 7 days and 14 days for assessing improvement in symptoms and signs for otomycosis.


  1. Data collection and Analysis: 

All data will be collected in google sheets and printed form in the form of a specific proforma for the study.

  1. Appropriate statistical tests - Chi square test will be applied to analyse the data as necessary.


 
Close